tirzepatide compound 10mg Research Peptide Tirzepatide 10mg | Dual GIP/GLP-1

Description

Endocrinology 108 , 3139 (1981)

According to clinical guidelines, a weight reduction of 5% from baseline is considered clinically meaningful for health benefits

Incretin mimetics delay gastric emptying, enhance satiety, and reduce appetite through central nervous system effects, leading to reduced caloric intake and 26 kg weight loss on average

The single best exercise intervention during a Retatrutide plateau is adding resistance training if you are not already doing it

This combination of increased usage and expanded state coverage has increased Medicaid spending on GLP-1s for obesity to more than $500 million in October 2024 alone, with total expenditures reaching $3.5 billion over the past 12 months